Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
Cingolani L, Barberio B, Zingone F, Ferronato A, Bertani L, Costa F, Bodini G, Demarzo MG, Melatti P, Gubbiotti A, Massimi D, Casadei C, D'Incà R, Savarino EV.
Cingolani L, et al. Among authors: demarzo mg.
Sci Rep. 2021 May 14;11(1):10368. doi: 10.1038/s41598-021-89790-4.
Sci Rep. 2021.
PMID: 33990652
Free PMC article.
Clinical Trial.